Carcinotech's 3D-bioprinted patient-derived tumors and holistic assay services are adding a new dimension to cancer biology and drug discovery.
We strive to ensure that individuals facing cancer can benefit from the most effective treatment options, improving both survival and quality of life.
By providing human-relevant cancer models, we help accelerate drug development, increasing the confidence of clinical trial success.
With our extensive repository of tumor biopsies and sourcing capabilities, we can provide the specific cancer indications required for your study.
These biopsies are then utilized to 3D-print tumors tailored to your research needs.
If you have already sourced your material, cell line, or patient tissue, we can utilize these to 3D-print tumors.
Harness the power of precision with our assay-ready, cancer models, part of our comprehensive preclinical oncology services.
We create patient-derived tumors that retain their native microenvironment, offering you highly relevant models for drug testing, optimization, and precision medicine.
Bridge resource gaps and accelerate your research with our expert scientific team.
We design and execute assays on your behalf, delivering the critical insights you need, faster and with precision.
Carcinotech provides comprehensive solid-tumor research services to advance drug development and enhance personalized therapy decisions.
